b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31638979</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>30</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>30</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1471-2490</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>19</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Oct</Month>\n                        <Day>21</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>BMC urology</Title>\n                <ISOAbbreviation>BMC Urol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>96</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12894-019-0531-z</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and the need for high ablative doses while preserving the remaining renal parenchyma is a challenge. We aimed to analyze the safety and efficacy of robotic radiosurgery in RCC in a specific difficult subgroup of patients with impaired renal function.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively identified all patients with RCC, treated with robotic SABR and motion compensation in our institution between 2012 and 2017. Either single fraction SABR of 24 or 25\xe2\x80\x89Gy or 3 fractions of 12\xe2\x80\x89Gy prescribed to the 70% isodose line was applied. Local control, overall survival, radiation side effects were evaluated together with renal function and tumor motion.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We analyzed data of 13 lesions treated in 10 patients with clear cell RCC and a mean age of 70.5\xe2\x80\x89\xc2\xb1\xe2\x80\x8913.6\xe2\x80\x89years (range: 48-87). Prior to SABR, 8 patients underwent previous complete and/or partial nephrectomy, 7 patients presented with chronic kidney disease \xe2\x89\xa5 stage 3. The median of minimum, mean and maximum planning target volume doses were 23.2, 29.5 and 35.0\xe2\x80\x89Gy for single fraction and 24.4, 42.5 and 51.4\xe2\x80\x89Gy for the three fractions regime. Persistent local control by robotic SABR was achieved in 9 out of 10 patients (92.3% of all lesions) within a median follow-up period of 27\xe2\x80\x89month (range: 15-54). One patient underwent nephrectomy due to progressive disease and sufficient renal function of the contralateral kidney. Renal function remained stable with a mean estimated glomerular filtration rate (eGFR) of 51.3\xe2\x80\x89\xc2\xb1\xe2\x80\x8919.7\xe2\x80\x89ml/min at baseline and 51.6\xe2\x80\x89\xc2\xb1\xe2\x80\x8925.8\xe2\x80\x89ml/min at follow-up. The largest respiratory-induced tumor motion was seen in superior-inferior direction, compensated by the CyberKnife with mean targeting errors of maximal 2.2\xe2\x80\x89mm.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Robotic SABR is technically feasible for the treatment of RCC in preexisting kidney disease with good local tumor control at about 2\xe2\x80\x89years follow-up. Robotic SABR with motion tracking offers a valid treatment option for patients, who are at increased risk for progression to end-stage renal disease due to partial nephrectomy or ablative techniques.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Senger</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7700-4657</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. carolin.senger@charite.de.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. carolin.senger@charite.de.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Conti</LastName>\n                    <ForeName>A</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, University of Messina, Messina, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kluge</LastName>\n                    <ForeName>A</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pasemann</LastName>\n                    <ForeName>D</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kufeld</LastName>\n                    <ForeName>M</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Acker</LastName>\n                    <ForeName>G</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery and Center for Stroke research Berlin (CSB), Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Charit\xc3\xa9platz 1, 10117, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Berlin Institute of Health (BIH), Anna-Louisa-Karsch-Str. 2, 10178, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lukas</LastName>\n                    <ForeName>M</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nuclear Medicine, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Charit\xc3\xa9platz 1, 10117, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gr\xc3\xbcn</LastName>\n                    <ForeName>A</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kalinauskaite</LastName>\n                    <ForeName>G</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Budach</LastName>\n                    <ForeName>V</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Waiser</LastName>\n                    <ForeName>J</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology and Medical Intensive Care, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Charit\xc3\xa9platz 1, 10117, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stromberger</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Radiation Oncology, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Charit\xc3\xa9 CyberKnife Center, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>21</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>BMC Urol</MedlineTA>\n            <NlmUniqueID>100968571</NlmUniqueID>\n            <ISSNLinking>1471-2490</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016634" MajorTopicYN="N">Radiosurgery</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CyberKnife</Keyword>\n            <Keyword MajorTopicYN="N">Kidney</Keyword>\n            <Keyword MajorTopicYN="N">Motion tracking</Keyword>\n            <Keyword MajorTopicYN="N">Radiosurgery</Keyword>\n            <Keyword MajorTopicYN="N">Renal cell carcinoma</Keyword>\n            <Keyword MajorTopicYN="N">SABR</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31638979</ArticleId>\n            <ArticleId IdType="doi">10.1186/s12894-019-0531-z</ArticleId>\n            <ArticleId IdType="pii">10.1186/s12894-019-0531-z</ArticleId>\n            <ArticleId IdType="pmc">PMC6805546</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Cancer. 2008 Nov 15;113(10):2671-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18816624</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1249-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7713786</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Urol. 2015 Mar;193(3):771-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25132240</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1442-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16109463</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BJU Int. 2017 Nov;120(5):623-630</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28188682</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22237781</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 1997 Dec 15;80(12 Suppl):2519-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9406705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Oncol. 2008;47(8):1578-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18607859</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BJU Int. 2012 Dec;110(11 Pt B):E737-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23107102</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Radiother Oncol. 2015 Oct;117(1):183-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26362723</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Strahlenther Onkol. 2015 Feb;191(2):125-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25159135</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2032882</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Kidney Int. 1994 Feb;45(2):411-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8164427</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Lett. 2014 Jul;8(1):355-360</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24959276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Urol. 2016 Oct;196(4):989-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27157369</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Strahlenther Onkol. 2014 Jan;190(1):26-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24052011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2018 Mar 1;124(5):934-942</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29266183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>AJR Am J Roentgenol. 2016 Mar;206(3):544-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26901010</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'